Nirmatrelvir/Ritonavir Reduces Risk of Hospitalization in At-Risk Outpatients.

Ebell, Mark H

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Nirmatrelvir/Ritonavir Reduces Risk of Hospitalization in At-Risk Outpatients.

Ebell, Mark H.

Ebell MH; University of Georgia, Athens, GA, USA.

Am Fam Physician ; 105(5): Online, 2022 05 01.

Article in English | MEDLINE | ID: covidwho-1929292

Subject(s)

COVID-19; Ritonavir; Hospitalization; Humans; Outpatients; Ritonavir/therapeutic use; SARS-CoV-2

Search on Google

Print

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Ritonavir / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am Fam Physician Year: 2022 Document Type: Article Affiliation country: United States

Similar

MEDLINE

LILACS

LIS

Search on Google

Print

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Ritonavir / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am Fam Physician Year: 2022 Document Type: Article Affiliation country: United States